Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
Phase of Trial: Phase III
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Saxagliptin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Jul 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 20 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.